martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 9, 2025

Stock market today: Dow and S&P 500 slip, Nasdaq rises as Fed meeting kicks off, JOLTS data shows openings rose

View original at finance.yahoo.com
Stock market today: Dow and S&P 500 slip, Nasdaq rises as Fed meeting kicks off, JOLTS data shows openings rose US stocks were mixed on Tuesday as the Federal Reserve's December policy meeting kicked off and federal data showed job openings unexpectedly ticked higher even as layoffs jumped…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump would be looking for a new Fed chair to immediately move to cut rates

    80% confidence
  • Exxon expects to hit new earnings and cash flow targets with no increase in capital while generating 17% return on capital employed

    80% confidence
  • Exxon is ahead of its 2030 emissions reduction plans

    80% confidence
  • OPEC can't really afford a $40 or $30 barrel outcome because capital for many member countries is not as loose as in the 2010s

    80% confidence
  • It would be irresponsible to set out Fed rate cut plans for the next six months

    80% confidence
  • Consumers remain intentional in their shopping behaviors with at-home-cooking trends continuing to benefit our brands within our Meals & Beverages portfolio that deliver quality, convenience and value

    80% confidence
  • We believe affordability concerns are pushing the housing market towards equilibrium as home prices are trending towards flat

    80% confidence
  • 55% of US homes are now 40+ years old and will require higher levels of maintenance, repair and renovations in the near future

    80% confidence
  • Several years ago when we began to transform this company, we did so with one objective: to fully unlock our competitive advantages. Today, our transformation is driving industry-leading results

    80% confidence
  • While our Snacks business continues to weather category softness, our brands remain highly relevant

    80% confidence
  • Tesla unsupervised FSD milestone is very close

    80% confidence
  • Affordability concerns and general uncertainty have led consumers to stay put in their homes

    80% confidence
  • We're observing several dynamics that are pressuring housing and unproven demand. First, the elevated interest rate and mortgage rate environment since 2020 has stifled housing turnover as a result of the mortgage lobby effect

    80% confidence
  • Trump's farm bailout would not be possible without tariffs

    80% confidence
  • Housing market experiencing soft demand and choppy conditions this year, though luxury business remains differentiated

    80% confidence
  • Americans' affordability concerns are a con job

    80% confidence
  • Pent-up demand from consumers putting off larger projects can be greater than $20 billion and at some point will be a significant tail

    80% confidence
  • Costs at JPMorgan would rise in 2026 amid competition in credit card space and as AI investments drive higher spending

    80% confidence
  • Housing turnover has remained at historical lows since 2023, which has significantly reduced demand for projects associated with buying and selling money

    80% confidence

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com